asthma
Conditions
Interventions
Experimental group:medications, asthma software and follow-up
control:medications and follow-up
Sponsors
Xiguan Community Healthcare Center, Jinhua City, Zhejiang Province
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Participants were eligible for inclusion if they were diagnosed with mild asthma or moderate asthma according to the guideline of Global Strategy for Asthma Management and Prevention (2016 update). The age at the time of enrollment ranged from 6 to 12 years. Children and their parents could use spacer, pressurized metered dose inhaler, asthma software, and Childhood Asthma Control Test. Patients and/or their children signed written informed consent.
Exclusion criteria
Exclusion criteria: 1. patients diagnosed with severe asthma; 2. negative asthma predictive index; 3. known or suspected rhinosinusitis, obstructive sleep apnea/hypopnea syndrome, rheumatic diseases, primary immunodeficiency, etc., 4. those with a history of bronchopulmonary dysplasia, bronchiectasis, tracheobronchomalacia, bronchiolitis obliterans, diffuse panbronchiolitis, pulmonary tuberculosis, other conditions likely to interfere with the study; 5. those who are unwilling to use ICS.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency of asthma exacerbation; | — |
Secondary
| Measure | Time frame |
|---|---|
| C-ACT scores; | — |
Countries
China
Contacts
Public ContactXubo Qian
Xiguan Community Healthcare Center, Jinhua City, Zhejiang Province, China
Outcome results
None listed